Abstract
Use of transcatheter aortic valve implantation (TAVI) to treat severe aortic stenosis (AS) has gained popularity over time, accompanied by an evolution of patient and clinical factors. We aimed to characterise these changes and evaluate their impact on TAVI outcomes. Prospective, single center
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
